MBBS (Gold Medalist) | MS (General Surgery, Gold Medalist) | MCh (Surgical Oncology, Gold Medalist)
Consultant Surgical Oncologist | Associate Professor and Research Head, Department of Surgical Oncology, IMS & SUM-II Bhubaneswar
Consultant, SUM Ultimate Medicare, Bhubaneswar
Former Consultant, Apollo Cancer Centres Bhubaneswar
Founder, ICanCaRe Odisha | Chairperson, Health Committee, AACCI Odisha
Oncology treatment refers to the comprehensive care provided to patients diagnosed with cancer, aiming to remove, control, or slow down the growth of cancer cells. It is managed by oncologists — doctors specialized in diagnosing and treating various types of cancer.
A half bone marrow transplant uses a half-matched donor, usually a parent, child, or sibling. Advances in treatment have improved its success, offering a viable option for those without a full match.
A full bone marrow transplant uses a donor with identical HLA markers, usually a sibling or matched registry donor, offering the best success rates and lower risk of complications.
Autologous bone marrow transplant (BMT) is used for blood cancers like lymphoma and multiple myeloma, as well as certain solid tumors and autoimmune diseases. It carries a lower risk of immune rejection since the patient’s own stem cells are used. Allogeneic BMT is indicated for blood cancers such as leukemia (AML, ALL, CML), along with myelodysplastic syndromes, aplastic anemia, and inherited disorders like sickle cell disease. The choice between autologous and allogeneic BMT depends on the disease, patient condition, and donor availability.
Chimeric Antigen Receptor T-cell (CAR-T) therapy is an advanced form of immunotherapy that modifies a patient’s own T cells to recognize and attack cancer cells more effectively. It is primarily used to treat certain types of blood cancers, such as B-cell leukemia, lymphoma, and multiple myeloma. CAR-T therapy has shown remarkable success in cases where traditional treatments like chemotherapy and radiation have failed. This cutting-edge treatment offers new hope for patients with relapsed or treatment-resistant cancers.
Chemotherapy is a widely used cancer treatment that involves powerful drugs to kill or slow the growth of cancer cells. It targets rapidly dividing cells, which is a key characteristic of cancer. However, it can also affect healthy cells, leading to various side effects. Chemotherapy is often used as a standalone treatment or in combination with other therapies such as surgery, radiation, or immunotherapy, depending on the type and stage of cancer.
Factor replacement therapy is a medical treatment used to replace missing or deficient clotting factors in individuals with bleeding disorders, such as hemophilia and von Willebrand disease. These clotting factors are essential proteins that help blood clot properly to prevent excessive bleeding. People with these conditions either lack specific clotting factors or have dysfunctional ones, leading to prolonged bleeding after injuries or spontaneous bleeding into joints and organs.
Immunotherapy is a cutting-edge cancer treatment that harnesses the body’s immune system to fight cancer cells. Unlike chemotherapy, which directly attacks cancer cells, immunotherapy strengthens or modifies the immune system to recognize and destroy cancer more effectively. This treatment is particularly effective against certain types of cancers, including melanoma, lung cancer, and some types of leukemia and lymphoma. Immunotherapy can be used alone or in combination with other treatments like chemotherapy, radiation, or surgery.
Leukapheresis is a specialized medical procedure used to remove excess white blood cells (leukocytes) from the bloodstream. This treatment is primarily used for patients with conditions such as leukemia, where abnormally high levels of white blood cells can cause complications. It is also used to collect white blood cells for research, immunotherapy, or stem cell transplants.
Plasmapheresis is a medical procedure that involves removing, treating, and returning plasma—the liquid part of the blood—to the body. This treatment is used for various conditions, including autoimmune diseases, neurological disorders, and certain blood-related conditions. It helps remove harmful substances such as autoantibodies, toxins, or abnormal proteins from the bloodstream, improving symptoms and preventing disease progression.
Targeted therapy is a specialized cancer treatment that focuses on specific molecules involved in cancer cell growth and survival. Unlike chemotherapy, which affects both cancerous and healthy rapidly dividing cells, targeted therapy is designed to block cancer growth while minimizing damage to normal cells. This approach is used for various cancers, including breast cancer, lung cancer, and certain types of leukemia, and is often combined with other treatments such as chemotherapy, radiation, or immunotherapy.
Guest Faculty, ARIS 2025, Hyderabad: Fluorescence-Guided Thoracic Duct Visualization in Robotic Surgery
Stryker National Observership Scholarship, Aster Oncology, April 2025: Advanced Breast Oncoplasty, Fluorescence-Guided Breast Surgeries, Intra-Operative Electron Therapy
Stryker National Observership Scholarship, Aster Oncology, Featured in Times of India, March 2025: Expert Voice for “Compassionate Cancer Care”
Awardee, “Women Shaping the Future”, BNI Women Conclave, March 2025: Keynote Speaker on Cancer Prevention
Organized the Largest Oncology Screening Camp, Nayagarh District, March 2025
Core Organizing Team & Faculty, IASO MIDCON Puri, February 2025
Advanced Robotic Surgery Observership, AIIMS New Delhi, February 2025:
Focused on Breast and Head & Neck Cancers Faculty Speaker, IASO ZONCON Rishikesh, February 2025:
Workshop on Oncoplastic Breast Surgery Speaker, FICCI FLO and Manipal Hospitals, Bhubaneswar, January 2025
Prevention of Cancer and Practical Oncology Tips Faculty, Frontiers of Uro-Onco Pathology International Congress,
January 2025: Panel Discussion on Renal Cancers Launched “Flo-Wer-Naari” Menstrual Hygiene and Cervical Cancer
accine Campaign, Nov 2024 Conducted Cancer Awareness Drives at IMS & SUM-II (October 2024)and Balasore Police Hospital (March 2024) Featured in Times of India (Jan 2024) as “Exponent of Compassionate
Comprehensive Cancer Care” Awarded Health Leader at Kanak News Health Conclave, November 2023
Editor and Author for Women’s Cancer Articles, Swasthya Sambad, 2023
Speaker and Jury Member for Young Achievers, Marwari Samaj Odisha, February 2023
Women Shaping the Future Award, BNI Women Conclave, 2025
Women Achievers in Healthcare Award, Times Group, 2024
Health Leader Award, Kanak News Health Conclave, 2023
Special Prize for Research in AI Oncology, Indian Cancer Congress, 2023
Featured in Times of India, 2024 & 2025 (Compassionate Cancer Care Expert Voice)
Most Promising Surgical Oncologist, Healthcare Awards Odisha, 2022
Corona Warrior Award, Odisha State, 2021
Triple Gold Medalist in MBBS, MS, MCh
Pioneering Preventive Oncology Awards, 2022–2025
Lorem ipsum, dolor sit amet consectetur adipisicing elit. Nihil ipsa iure quibusdam quidem rem debitis, architecto illum omnis asperiores dolore fugiat ad perferendis maiores ducimus alias, eius voluptas? Necessitatibus, ipsa!
© Dr. Arijit Bishnu. All Rights Reserved.
Designed by Digiex Web
Dr. Garima Sarawgi